NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-297-2002-0-US-02 Methods of Preparing Lymphocytes that Express Interleukin-2 (IL-2) and Their Use in the Treatment of Cancer US ORD 10/531,145 7381405 Abandoned PDF
NCI E-245-2002-0-US-03 AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF US National Stage 10/526,851 7378403 Abandoned PDF
NCI E-031-2003-1-US-01 Immunogenic Epitopes for Fibroblast Growth Factor 5 (FGF-5) US CIP 11/134,703 Abandoned
NHLBI E-247-2004-0-PCT-02 MRI Active Interventional Devices For Vascular Interventions And Particularly Recanalzing Total Occlusions In The Vasculature. PCT PCT PCT/US2005/017351 Expired
NHLBI E-247-2004-0-US-04 MRI Active Interventional Devices For Vascular Interventions And Particularly Recanalzing Total Occlusions In The Vasculature. US DIV 12/654,607 Abandoned
NHLBI E-247-2004-0-US-03 MRI Active Interventional Devices For Vascular Interventions And Particularly Recanalzing Total Occlusions In The Vasculature. US ORD 11/131,304 Abandoned
NCI E-339-2002-0-US-03 Method and Apparatus for Performing Multiple Simultaneous Manipulations of Biomolecules in Two-Dimensional Array US National Stage 10/535,521 Abandoned
NIDDK E-171-2003-1-US-02 Purine Nucleosides US National Stage 10/530,552 7199127 Expired PDF
NCI E-261-2003-0-PCT-02 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION PCT PCT PCT/US2005/17001 Expired
NCI E-261-2003-0-IN-07 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION IN National Stage 6817/DELNP/2006 Abandoned
NIA E-187-2002-0-US-09 Pure Populations of Astrocytected Precursor from Rodent and Human Restricted Precursor Cells and Methods for Isolation and use Thereof US National Stage 10/502,224 Abandoned
NCI E-261-2003-0-CN-05 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION CN National Stage 200580023731.7 Abandoned
NCI E-261-2003-0-EP-06 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION EP National Stage 05747678.0 Abandoned
NCI E-261-2003-0-CA-04 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION CA National Stage 2566572 Abandoned
NCI E-261-2003-0-AU-03 GENE-CASSETTE FOR ENHANCEMENT OF PROTEIN PRODUCTION AU National Stage 2005248350 Abandoned
NCI E-143-1998-0-US-05 NOVEL POST-TRANSCRIPTIONAL REGULATORY ELEMENTS AND USES THEREOF US DIV 11/130,545 Abandoned
NCI E-208-2005-0-US-01 Anti-CD30 Antibodies That Bind to Intact CD30 But Not Soluble CD30 US 60/681,929 Abandoned
NIAID E-168-2004-0-US-01 Linking Malarial Proteins To OMPC Greatly Increases The Antibody Response To The Protein US 60/681,546 Abandoned
NCI E-007-2004-1-US-01 Pyrrolobenzodiazepines US CIP 11/129,207 7244724 Abandoned PDF
NINDS E-192-2004-0-PCT-02 Compositions and Methods for Diagnosis and Treatment of Chemotherapy-Resistant Neoplastic Disease PCT PCT PCT/US2005/016924 Abandoned
NIAID E-218-2004-0-PCT-02 HIV Vaccine Immunogens and Immunization Strategies to Elicit Broadly Neutralizing Anti-HIV-1 Against the Membrane-Proximal Ectodomain of HIV Gp41 PCT PCT PCT/US2005/016633 Expired
NIAID E-051-2005-0-US-01 Identification Of A Fusion/Entry Receptor For Human Herpesvirus-8 US 60/681,098 Abandoned
NIEHS E-130-2004-0-EP-05 Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions EP National Stage 05750004.3 Abandoned
NIEHS E-130-2004-0-CA-04 Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions CA National Stage 2566445 Issued
NIEHS E-130-2004-0-AU-03 Methods Related To The Treatment Of Neurodegenerative And Inflammatory Conditions AU National Stage 2005244852 Issued
NIEHS E-130-2004-0-PCT-02 Methods For The Treatment Of Neurodegenerative And Inflammatory Conditions. PCT PCT PCT/US2005/16691 Expired
NHLBI E-010-2003-0-US-03 Method And Devices For Image-Guided Catheter-based Percutaneous Repair Of Regurgitant Cardiac Valves US National Stage 11/127,112 Abandoned
NCI E-155-2005-1-US-01 T Cell -Binding Epitopes From The Human Papillomavirus Type 16 E2 Region That Induce Significant CD8+T Cell Response And CTL Lysis Activity Both Bound To HLAA2 And When Pulsed As Peptide US 60/680,000 Abandoned
NCI E-015-2005-0-US-01 Anti-Mesothelin Antibodies Useful for Immunological Assays US 60/681,104 Abandoned
NHLBI E-037-2003-1-US-02 METHOD FOR THE DIAGNOSIS AND TREATMENT OF VASCULAR DISEASE US National Stage 10/534,626 7708977 Expired PDF
NIDCR E-614-1987-0-DK-23 DNA ENCODING IgE RECEPTOR ALPHA-SUBUNIT OR FRAGMENT THEREOF DK National Stage PA200500682 Expired
NCI E-185-2004-2-PCT-01 Tricyclic Compounds as Inhibitors of the Hypoxic Signaling Pathway PCT PCT COMB PCT/US05/16569 Abandoned
NIA E-016-2004-0-PCT-02 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin PCT PCT PCT/US2005/16565 Expired
NIA E-016-2004-0-KR-06 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin KR National Stage 10-2006-7026085 Abandoned
NIA E-016-2004-0-EP-03 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin EP National Stage 05747960.2 Abandoned
NIA E-016-2004-0-CA-04 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin CA National Stage 2566703 Abandoned
NIA E-016-2004-0-JP-08 Method of Inhibiting Profinflammatory Cytokine Expression Using Ghrelin JP DIV 2011-11457 Abandoned
NCI E-084-2005-0-US-04 Multiple High-resolution Serum Proteomic Features For Ovarian Cancer Detectionq US National Stage 11/093,018 Abandoned
NCI E-166-2003-0-US-04 Nanoparticular Tumor Targeting And Therapy US CON 11/125,438 Abandoned
NIAID E-108-2005-0-US-01 COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE, UTILIZING NF-KB DECOY POLYNUCLEOTIDES US ORD 11/125,919 Abandoned
NIAID E-198-2005-0-US-01 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses US 60/679,767 Abandoned
NCI E-294-2002-0-JP-07 A New Target for Angiogenesis and Anti-Angiogenesis Therapy JP National Stage 2004-551922 Abandoned
NCI E-112-2006-1-US-01 Synthesis Of Indenoisoquinolines US CIP 11/125,723 7495100 Issued PDF
NCI E-275-2002-1-US-02 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy US National Stage 10/526,697 8034334 Issued PDF
NCI E-139-2007-0-US-01 Methods And Compositions For Detecting Immune Responses US 60/678,329 Abandoned
NIAID E-203-2005-0-US-01 HIV-Encodes An Si RNA, MicroRNA Sequences and Suppressor of RNA Silencing US 60/677,839 Abandoned
NCI E-004-2005-2-US-01 Human Monoclonal Antibodies Against Hendra And Hipah US 60/678,547 Abandoned
NCI E-167-2007-0-VN-12 Antigenic Peptides VN National Stage 1-2005-00592 Abandoned
NIAID E-319-2004-1-US-01 Optimized Vaccines to Provide Protection Against Ebola and Other Viruses US 60/677,606 Abandoned
NIAID E-318-2004-0-US-02 Regulation Of ATG-7-Beclin 1 Program Of Autophagic Cell Death By Caspase-8 US ORD 11/119,569 7838645 Abandoned PDF